Light Sciences files for $86 million IPO
Light Sciences Oncology has filed for an IPO designed to raise $86 million. The Seattle, WA-based company is developing a drug-device called Litx, which uses a water-soluble drug to kill cancer cells activated by a light-emitting wand. The therapy has been approved in Japan. Light Sciences raised $67 million in its first round late last year.
- read the Seattle Times article
ALSO: Acadia Pharmaceuticals plans to sell $75 million in stock. Report
Comments